Inactive Instrument

Company Iomai Corporation

Equities

US46202P1030

Pharmaceuticals

End-of-day quote Nasdaq
- - Intraday chart for Iomai Corporation

Business Summary

Intercell USA, Inc. provides products for the delivery of vaccines to the skin through a proprietary technology known as transcutaneous immunization, or TCI. The Company is evaluating skin immunization techniques in several human clinical trials, including those to prevent influenza in the healthy adult and elderly populations, and also to prevent travelers' diarrhea and anthrax infection.

Managers

Managers TitleAgeSince
Director/Board Member 54 -
Director/Board Member 58 15-11-30
Corporate Officer/Principal - 08-07-31
Human Resources Officer - 96-12-31
Corporate Officer/Principal - -
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 81 05-12-31
Director/Board Member 61 17-10-31
Director/Board Member 85 06-07-04
Director/Board Member 71 01-12-31
Director/Board Member 58 15-11-30
Director/Board Member 54 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 25,601,344 19,300,000 ( 75.39 %) 0 75.39 %

Company contact information

Intercell USA, Inc.

20 Firstfield Road Suite 250

20878, Gaithersburg

+

http://www.iomai.com
address Iomai Corporation
  1. Stock Market
  2. Equities
  3. Stock
  4. Company Iomai Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW